Search

everythinglearnresearchcommunity

for

Search:↓

ABCG2 protein marks stem-like skin cells in human epidermis.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Defective protein folding due to a mutation is key in ANE syndrome.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Ancient DNA blocks are still present in human genomes, possibly due to advantages they provide.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

A good skin care routine improves happiness, self-esteem, and overall quality of life.

Researchers should follow the FACE-Q User's Guide for accurate results.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Younger women are seen as more attractive and healthier, with Chinese women rated highest and South African women rated oldest and least healthy.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Using scalp micropigmentation (a special tattoo technique) with hair transplantation can effectively treat hair loss, especially for those with low donor density or those unsuitable for only hair transplantation.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

Good communication helps predict successful aging in older Indonesians.

Female pattern hair loss does not significantly affect sexual dysfunction.

Shift work disrupts the body's natural clock, leading to health problems.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Burn care for the elderly needs improvement, with more research and specific guidelines required.

The pandemic worsened physical and mental challenges for women with PCOS.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.